Oncogene - Table of Contents alert Volume 34 Issue 40

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 34, Issue 40 (October 2015) In this issue Review Original Articles Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Review Top Cell death by autophagy: emerging molecular mechanisms and implications for cancer therapy S Fulda and D Kögel Oncogene 2015 34: 5105-5113; advance online publication, January 26, 2015; 10.1038/onc.2014.458 Abstract | Full Text Original Articles Top Platelet-activating factor receptor-mediated PI3K/AKT activation contributes to the malignant development of esophageal squamous cell carcinoma J Chen, T Lan, W Zhang, L Dong, N Kang, S Zhang, M Fu, B Liu, K Liu, C Zhang, J Hou and Q Zhan Oncogene 2015 34: 5114-5127; advance online publication, February 2, 2015; 10.1038/onc.2014.434 Abstract | Full Text SREBP maintains lipid biosynthesis and viability of cancer cells under lipid- and oxygen-deprived conditions and defines a gene signature associated with poor survival in glioblastoma multiforme C A Lewis, C Brault, B Peck, K Bensaad, B Griffiths, R Mitter, P Chakravarty, P East, B Dankworth, D Alibhai, A L Harris and A Schulze Oncogene 2015 34: 5128-5140; advance online publication, January 26, 2015; 10.1038/onc.2014.439 Abstract | Full Text KLHL39 suppresses colon cancer metastasis by blocking KLHL20-mediated PML and DAPK ubiquitination H Y Chen, J Y Hu, T H Chen, Y C Lin, X Liu, M Y Lin, Y D Lang, Y Yen and R H Chen Oncogene 2015 34: 5141-5151; advance online publication, January 26, 2015; 10.1038/onc.2014.435 Abstract | Full Text p73 engages A2B receptor signalling to prime cancer cells to chemotherapy-induced death OPEN J S Long, P M Schoonen, D Graczyk, J O'Prey and K M Ryan Oncogene 2015 34: 5152-5162; advance online publication, February 9, 2015; 10.1038/onc.2014.436 Abstract | Full Text TM9SF4 is a novel V-ATPase-interacting protein that modulates tumor pH alterations associated with drug resistance and invasiveness of colon cancer cells F Lozupone, M Borghi, F Marzoli, T Azzarito, P Matarrese, E Iessi, G Venturi, S Meschini, A Canitano, R Bona, A Cara and S Fais Oncogene 2015 34: 5163-5174; advance online publication, February 9, 2015; 10.1038/onc.2014.437 Abstract | Full Text Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8–Akt–Slug pathway C Visciano, F Liotti, N Prevete, G Cali', R Franco, F Collina, A de Paulis, G Marone, M Santoro and R M Melillo Oncogene 2015 34: 5175-5186; advance online publication, January 26, 2015; 10.1038/onc.2014.441 Abstract | Full Text MUC1-C activates the TAK1 inflammatory pathway in colon cancer H Takahashi, C Jin, H Rajabi, S Pitroda, M Alam, R Ahmad, D Raina, M Hasegawa, Y Suzuki, A Tagde, R T Bronson, R Weichselbaum and D Kufe Oncogene 2015 34: 5187-5197; advance online publication, February 9, 2015; 10.1038/onc.2014.442 Abstract | Full Text A novel recurrent CHEK2 Y390C mutation identified in high-risk Chinese breast cancer patients impairs its activity and is associated with increased breast cancer risk N Wang, H Ding, C Liu, X Li, L Wei, J Yu, M Liu, M Ying, W Gao, H Jiang and Y Wang Oncogene 2015 34: 5198-5205; advance online publication, January 26, 2015; 10.1038/onc.2014.443 Abstract | Full Text Corrigendum Top The epigenetic regulator UHRF1 promotes ubiquitination-mediated degradation of the tumor-suppressor protein promyelocytic leukemia protein D Guan, D Factor, Yu Liu, Z Wang and H-Y Kao Oncogene 2015 34: 5206; 10.1038/onc.2015.314 Full Text Advertisement Oncogenesis is an online-only, open access journal exploring the molecular basis of cancer and related phenomena. The journal seeks to promote diverse and integrated areas of molecular biology, cell biology, oncology, and genetics. The journal has an Impact Factor of 3.952. Explore the benefits of submitting your next research article: http://bit.ly/1vUuaXe Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.